How have ACUR shares performed in 2024?

Acura Pharmaceuticals' stock was trading at $0.0001 on January 1st, 2024. Since then, ACUR stock has increased by 2,700.0% and is now trading at $0.0028. View the best growth stocks for 2024 here .

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) announced its earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 EPS for the quarter. The specialty pharmaceutical company earned $1.32 million during the quarter.

What other stocks do shareholders of Acura Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI) , Adamis Pharmaceuticals (ADMP) , Ekso Bionics (EKSO) , VIVUS (VVUS) , Fulcrum Therapeutics (FULC) , (GBSN) (GBSN) , Trevena (TRVN) , AcelRx Pharmaceuticals (ACRX) , Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD) .

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Acura Pharmaceuticals have any subsidiaries?

The following companies are subsidiares of Acura Pharmaceuticals: Acura Pharmaceutical Technologies Inc.. Read More

OTCMKTS:ACUR

Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)

Free ACUR Stock Alerts

$0.0028

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.0028
▼
$0.0028
50-Day Range: N/A
52-Week Range: $0.00
▼
$0.05

Volume: 4,050 shs
Average Volume: 3,228 shs
Market Capitalization: $185,780.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Acura Pharmaceuticals alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

ACUR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ACUR Stock News Headlines

February 28, 2024 | benzinga.com

Acura Pharmaceuticals Stock (OTC:ACUR), Insider Trading Activity

February 10, 2024 | yahoo.com

Robert Kraft's foundation wants people to "stand up to hate" with Super Bowl ad

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 5, 2024 | msn.com

American Honda reports 10.3% Y/Y sales growth in January amid a sequential decline

January 13, 2024 | morningstar.com

Acura Pharmaceuticals Inc ACUR

November 20, 2023 | yahoo.com

Cumberland man jailed in alleged death threat against district court judge

September 26, 2023 | news.yahoo.com

Miami man distributed over $16 million of adulterated HIV drugs given to U.S. patients

August 24, 2023 | finance.yahoo.com

Acura Pharmaceuticals, Inc. (ACUR)

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

August 12, 2023 | forbes.com

Acura Extended Warranty Review: Everything You Need To Know

June 30, 2023 | au.finance.yahoo.com

ACUR - Acura Pharmaceuticals, Inc.

May 31, 2023 | msn.com

Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer

May 3, 2023 | marketwatch.com

Exploring the Growth Potential of the Opioid Drugs Market till 2031

April 27, 2023 | marketwatch.com

Azilsartan Medoxomil API Market Forecast to 2030

April 22, 2023 | thestreet.com

4 Stocks Under $10 Moving Higher

April 9, 2023 | benzinga.com

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023: One-Stop Source for Providing Real-Deal Information on Hundreds of Transactions

April 9, 2023 | marketwatch.com

Opioid Drugs Market Sales By 2030

March 29, 2023 | marketwatch.com

Calming and Sleeping Market Outlook and Forecast till 2028

March 13, 2023 | thestreet.com

Acura Stock Soars (ACUR)

February 17, 2023 | marketwatch.com

Opioid Drugs Market Forcast 2023 To 2028 : In-depth Research Analysis with Top Countries Data

February 13, 2023 | marketwatch.com

Azilsartan Medoxomil API Market 2023-2029 Global Forecast with Top Key Players such as: Takeda, Lupin, Acura Labs, Metrochem API

February 8, 2023 | marketwatch.com

Opioid Drugs Market Global Demand, Opportunities, Trends, Analysis and Forecast to 2028

January 25, 2023 | marketwatch.com

Analysis of Azilsartan Medoxomil API Market for the Period 2023 to 2028 : Development, Growth and Key Factors

January 5, 2023 | thestreet.com

Pfizer, Acura Painkiller Approved by FDA

September 4, 2022 | msn.com

Woman shot in face, hand in drive-by shooting on Queens street, 2 vehicles sought

August 18, 2022 | marketwatch.com

Calming and Sleeping Market Size and Growth 2022 Analysis Report by Manufactures, Trends, Share, Opportunity, Regions and Forecast to 2028

July 10, 2022 | morningstar.com

Acura Pharmaceuticals Inc - Stock Quote ACUR

See More Headlines

Receive ACUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2020
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: Pharmaceuticals
Current Symbol: OTCMKTS:ACUR
Previous Symbol: NASDAQ:ACUR
CUSIP: 00509L70
CIK: 786947
Web: www.acurapharm.com
Phone: (847) 705-7709
Fax: 847-705-5399
Employees: 9
Year Founded: 1935

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $1.56 million
Price / Sales: 0.12
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 66,350,000
Free Float: 52,947,000
Market Cap: $185,780.00
Optionable: Not Optionable
Beta: 1.89

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Robert B. Jones (Age 65)
CEO, President & Director
Comp: $150k
Mr. Peter A. Clemens (Age 71)
Senior VP, CFO & Secretary
Comp: $200k
Mr. Robert A. Seiser CPA (Age 60)
Ph.D., VP, Treasurer & Corporate Controller
Comp: $210.2k

Key Competitors

View All Competitors

ACUR Stock Analysis - Frequently Asked Questions

How have ACUR shares performed in 2024?: Acura Pharmaceuticals' stock was trading at $0.0001 on January 1st, 2024. Since then, ACUR stock has increased by 2,700.0% and is now trading at $0.0028.
View the best growth stocks for 2024 here.
How were Acura Pharmaceuticals' earnings last quarter?: Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) announced its earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 EPS for the quarter. The specialty pharmaceutical company earned $1.32 million during the quarter.
What other stocks do shareholders of Acura Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), VIVUS (VVUS), Fulcrum Therapeutics (FULC), (GBSN) (GBSN), Trevena (TRVN), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD).

How do I buy shares of Acura Pharmaceuticals?: Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Acura Pharmaceuticals have any subsidiaries?: The following companies are subsidiares of Acura Pharmaceuticals: Acura Pharmaceutical Technologies Inc..
Read More

This page (OTCMKTS:ACUR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis

About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)

ACUR Stock Price History

ACUR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

ACUR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info